130 likes | 291 Views
PD-12 Update on Changes to MCCSR Mortality Factor Dan Doyle. AGENDA. Review proposal Survey results Recommendations. PROPOSAL. Compute volatility component at major product line level, then aggregate:. Standard deviation. Net Face. ln(duration). NAAR. PROPOSAL.
E N D
AGENDA • Review proposal • Survey results • Recommendations PwC
PROPOSAL • Compute volatility component at major product line level, then aggregate: Standard deviation Net Face ln(duration) NAAR PwC
PROPOSAL • - Groupings based on similar durations and adjustability • - 50% for adjustable products • - Includes ADB coverage's PwC
PROPOSAL • Catastrophe Component • CC = .1 x C x G/H • 50% for adjustable • Sum all lines for total PwC
PROPOSAL • Group - Lack of Seriatim Data • B = 1 for adjustable • B = 2 for non-adjustable PwC
SURVEY • - Second survey sent to respondents of first • - Results for 35 companies are shown PwC
SURVEY PwC
SURVEY • Overall improvements in Ratios – 6% • Companies with higher mortality variance (risk) require more capital • Current formula does not adequately reflect underlying risks PwC
SURVEY • Regulators following up with extreme outiers • Overall comments were favourable PwC
SURVEY • Comments: • No explicit credit for MFAD or premium • Difficulty in projection • Approximation PwC
RECOMMENDATIONS • Lead time (transition) • Continue review • 50% factor • MFAD • Models PwC
Sub-Committee members • Ben Meckler (Chair) • Marc-Andre Belzil • Bill Brath • Gord Challes • Dan Doyle Jean-Guy Lapointe Les Rehbeli Sylvain St-Georges Jim Witol PwC